| 1 | [SID49822895] | Active | AC50 | 3.5 | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity [AID651703, Type: confirmatory] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | AC50 | 3.5 [uM] | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651703 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 2 | [SID49822895] | Active | AC50 | 3.5 | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity [AID651703, Type: confirmatory] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | AC50 | 3.5 [uM] | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_Dose_CherryPick_Activity | | AID | 651703 | | BioAssay type | confirmatory | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 3 | [SID49822895] | Active | Potency | 5.1735 | qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells [AID2685, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells | | AID | 2685 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID49822895] | Active | AC50 | 19.98 | ARNT-TACC3: counter AlphaScreen Measured in Biochemical System Using Plate Reader - 2158-02_Inhibitor_Dose_CherryPick_Activity [AID651705, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | AC50 | 19.98 [uM] | | BioAssay | ARNT-TACC3: counter AlphaScreen Measured in Biochemical System Using Plate Reader - 2158-02_Inhibitor_Dose_CherryPick_Activity | | AID | 651705 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID49822895] | Active | Potency | 20.5962 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID49822895] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 7 | [SID49822895] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 8 | [SID49822895] | Active | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID49822895] | Active | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 10 | [SID49822895] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 11 | [SID49822895] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 12 | [SID49822895] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 13 | [SID49822895] | Active | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 14 | [SID49822895] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 15 | [SID49822895] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID49822895] | Inactive | Potency | 0.3162 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | 0.3162 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 17 | [SID49822895] | Inactive | Potency | 3.5481 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 18 | [SID49822895] | Inactive | Potency | 3.5481 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 19 | [SID49822895] | Inactive | Potency | 50.1187 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 20 | [SID49822895] | Inactive | IC50 | 79 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage [AID588779, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage | | AID | 588779 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID49822895] | Inactive | IC50 | 79 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage using 2-dexoy-glucose [AID588780, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage using 2-dexoy-glucose | | AID | 588780 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID49822895] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID49822895] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID49822895] | Inactive | Potency | | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID49822895] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID49822895] | Inactive | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID49822895] | Inactive | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID49822895] | Inactive | | | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells [AID602274, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells | | AID | 602274 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID49822895] | Inactive | | | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity [AID602340, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity | | AID | 602340 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID49822895] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity [AID602342, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602342 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID49822895] | Inactive | | | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity [AID602363, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity | | AID | 602363 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID49822895] | Inactive | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID49822895] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity [AID623901, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity | | AID | 623901 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID49822895] | Inactive | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID49822895] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID49822895] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID49822895] | Inactive | | | uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay [AID651582, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay | | AID | 651582 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID49822895] | Inactive | | | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity [AID651640, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity | | AID | 651640 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID49822895] | Inactive | | | HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity [AID651654, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651654 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID49822895] | Inactive | | | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity [AID651661, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651661 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID49822895] | Inactive | | | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity [AID651687, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651687 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID49822895] | Inactive | | | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library [AID651702, Type: screening] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library | | AID | 651702 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID49822895] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. [AID2023, Type: screening] | LAP4 [Saccharomyces cerevisiae] [gi:486173] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN. | | AID | 2023 | | BioAssay type | screening | | Target | LAP4 [Saccharomyces cerevisiae] [gi:486173] | | PubMed | | | Data Table |  |
|
| 44 | [SID49822895] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. [AID2025, Type: screening] | RPL19A [Saccharomyces cerevisiae] [gi:536029] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN. | | AID | 2025 | | BioAssay type | screening | | Target | RPL19A [Saccharomyces cerevisiae] [gi:536029] | | PubMed | | | Data Table |  |
|
| 45 | [SID49822895] | Inactive | Potency | | Activators of T cell receptors: qHTS campaign [AID504894, Type: confirmatory] | T cell receptor [Homo sapiens] [gi:553160] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Activators of T cell receptors: qHTS campaign | | AID | 504894 | | BioAssay type | confirmatory | | Target | T cell receptor [Homo sapiens] [gi:553160] | | PubMed | | | Data Table |  |
|
| 46 | [SID49822895] | Inactive | | | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound [AID1979, Type: screening] | heat shock protein 90 [Candida albicans] [gi:994798] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound | | AID | 1979 | | BioAssay type | screening | | Target | heat shock protein 90 [Candida albicans] [gi:994798] | | PubMed | | | Data Table |  |
|
| 47 | [SID49822895] | Inactive | Potency | | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 48 | [SID49822895] | Inactive | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. [AID2016, Type: screening] | MEP2 [Saccharomyces cerevisiae] [gi:1302091] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. | | AID | 2016 | | BioAssay type | screening | | Target | MEP2 [Saccharomyces cerevisiae] [gi:1302091] | | PubMed | | | Data Table |  |
|
| 49 | [SID49822895] | Inactive | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 50 | [SID49822895] | Inactive | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49822895 | | CID | 56642876 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|